Tag Archives | antiviral

June Gloom Continues : ASCO Buzz is Off But VRUS Soars

Stocks Down for Sixth Straight Session:  Biotechs still up Over 10% YTD As we wind down from ASCO news with few catalysts ahead, investors and traders will regroup and rebalance their portfolios. The NASDAQ index is down 21 pts off 0.77%  and component biotech stocks in the NASDAQ-100 are caught in the buyer’s strike . […]

Continue Reading 0

Gilead Sciences revenues and profits up sharply on antiviral drugs

Gilead (GILD) shares were up 6% to $47.75 after the close as the Company announced record sales and earnings. Full Year total Revenues were $7.01B up 31% over 2008. Full Year Non-GAAP EPS were $3.06 up 40% over 2008. Fourth Quarter Non-GAAP EPS were $0.93 up 49% over 2008. Average analysts revenue estimates for 2010 […]

Continue Reading 0